Copyright
©The Author(s) 2018.
World J Gastroenterol. Oct 7, 2018; 24(37): 4230-4242
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4230
Published online Oct 7, 2018. doi: 10.3748/wjg.v24.i37.4230
Biomarker | Alteration | Outcome | Ref. |
Malondialdehyde | High circulating levels | Lower survival | [] |
Total antioxidant capacity | High circulating levels | Lower survival | [29] |
Caspase-cleaved cytokeratin-18 | High circulating levels | Lower survival | [54] |
Soluble CD40 ligand | High circulating levels | Lower survival | [80] |
Substance P | High circulating levels | Lower survival | [107] |
Neutrophil to lymphocyte ratio | High circulating ratio | Lower survival | [120] |
Platelet to lymphocyte ratio | High circulating ratio | Lower survival | [120] |
C-reactive protein | High circulating levels | Lower survival | [121,122] |
Des-gamma-carboxy prothrombin | High circulating levels | Higher recurrence | [123-127] |
Glypican-3 | High HCC expression | Higher recurrence | [128] |
H-TERT mRNA | High peripheral blood expression | Lower survival | [130,131] |
E-cadherin | High HCC expression | Higher recurrence | [142] |
Beta-catenin | High HCC expression | Higher recurrence | [142] |
Dickkopf-1 | High HCC expression | Lower survival | [154] |
Vascular endothelial growth factor | High circulating levels | Lower survival | [156] |
- Citation: Lorente L. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinoma. World J Gastroenterol 2018; 24(37): 4230-4242
- URL: https://www.wjgnet.com/1007-9327/full/v24/i37/4230.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i37.4230